Attovia Therapeutics, Inc. (ATTO)

SEC filing

Attovia Therapeutics, Inc.

ATTO · CIK 2058707

4/A · Oct 8, 2026 · Director, President and CEO Fu Tao was granted 538.30K Stock Option (Right to Buy)

4/A

Director, President and CEO Fu Tao was granted 538.30K Stock Option (Right to Buy)

Could not load the primary document from EDGAR (SEC rate limit, timeout, or temporary upstream error). Refresh in a minute, or use View on SEC.gov.